135 related articles for article (PubMed ID: 15552798)
21. Receptor-mediated mitogenic signals and lung cancer.
Schüller HM
Cancer Cells; 1991 Dec; 3(12):496-503. PubMed ID: 1668140
[TBL] [Abstract][Full Text] [Related]
22. P2 receptors and cancer.
White N; Burnstock G
Trends Pharmacol Sci; 2006 Apr; 27(4):211-7. PubMed ID: 16530853
[TBL] [Abstract][Full Text] [Related]
23. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
24. Molecular networks in respiratory epithelium carcinomas.
Pallis AG; Karamouzis MV; Konstantinopoulos PA; Papavassiliou AG
Cancer Lett; 2010 Sep; 295(1):1-6. PubMed ID: 20381956
[TBL] [Abstract][Full Text] [Related]
25. Other compounds and targets in non-small cell lung cancer.
Villaflor V; Bonomi P
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S30-6. PubMed ID: 16459177
[TBL] [Abstract][Full Text] [Related]
26. NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy.
Shen HM; Tergaonkar V
Apoptosis; 2009 Apr; 14(4):348-63. PubMed ID: 19212815
[TBL] [Abstract][Full Text] [Related]
27. [Drug resistance mediated by survival- and growth-promoting signaling pathways].
Fujita N
Gan To Kagaku Ryoho; 2009 Apr; 36(4):567-71. PubMed ID: 19381028
[TBL] [Abstract][Full Text] [Related]
28. Antineoplastic effect of proliferation signal inhibitors: from biology to clinical application.
Bertoni E; Salvadori M
J Nephrol; 2009; 22(4):457-62. PubMed ID: 19662600
[TBL] [Abstract][Full Text] [Related]
29. The roles of therapy-induced autophagy and necrosis in cancer treatment.
Amaravadi RK; Thompson CB
Clin Cancer Res; 2007 Dec; 13(24):7271-9. PubMed ID: 18094407
[TBL] [Abstract][Full Text] [Related]
30. How to develop a successful cancer drug--molecules to medicines or targets to treatments?
Newell DR
Eur J Cancer; 2005 Mar; 41(5):676-82. PubMed ID: 15763642
[TBL] [Abstract][Full Text] [Related]
31. Novel targets for lung cancer therapy: part I.
Dy GK; Adjei AA
J Clin Oncol; 2002 Jun; 20(12):2881-94. PubMed ID: 12065566
[TBL] [Abstract][Full Text] [Related]
32. Integrating new targeted agents into the treatment of non-small-cell lung cancer.
Thatcher N
Lung Cancer; 2006 Dec; 54 Suppl 2():S25-31. PubMed ID: 17056150
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus expressing shRNA to IGF-1R enhances the chemosensitivity of lung cancer cell lines by blocking IGF-1 pathway.
Lee YJ; Imsumran A; Park MY; Kwon SY; Yoon HI; Lee JH; Yoo CG; Kim YW; Han SK; Shim YS; Piao W; Yamamoto H; Adachi Y; Carbone DP; Lee CT
Lung Cancer; 2007 Mar; 55(3):279-86. PubMed ID: 17134788
[TBL] [Abstract][Full Text] [Related]
34. Endocrine therapy and other targeted therapies for metastatic breast cancer.
Hussain SA; Palmer DH; Moon S; Rea DW
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1179-95. PubMed ID: 15606341
[TBL] [Abstract][Full Text] [Related]
35. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.
Schiff R; Massarweh SA; Shou J; Bharwani L; Arpino G; Rimawi M; Osborne CK
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():10-20. PubMed ID: 16273359
[TBL] [Abstract][Full Text] [Related]
36. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Jazirehi AR; Bonavida B
Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
[TBL] [Abstract][Full Text] [Related]
37. Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors.
Powers MV; Workman P
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S125-35. PubMed ID: 17259553
[TBL] [Abstract][Full Text] [Related]
38. Targeted therapy for non-small cell lung cancer.
Toloza EM; D'Amico TA
Semin Thorac Cardiovasc Surg; 2005; 17(3):199-204. PubMed ID: 16253823
[TBL] [Abstract][Full Text] [Related]
39. New targeted treatments in lung cancer--overview of clinical trials.
Korfee S; Gauler T; Hepp R; Pöttgen C; Eberhardt W
Lung Cancer; 2004 Aug; 45 Suppl 2():S199-208. PubMed ID: 15552800
[TBL] [Abstract][Full Text] [Related]
40. Developmental signalling pathways in lung cancer.
Daniel VC; Peacock CD; Watkins DN
Respirology; 2006 May; 11(3):234-40. PubMed ID: 16635080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
